Cellebrite DI Ltd. submitted its 6-K filing reporting consolidated financial statements and an operating review for the six months ending June 30, 2024. The filing is dated August 15, 2024, indicating its significance for investors. The sentiment is neutral, and it is considered a significant event as it outlines the company’s financial health.